Skip to main content

Advertisement

Log in

Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to determine if bone metastasis characteristics on axial skeleton MRI are associated with either skeletal-related events (SREs) or survival in breast cancer patients. A retrospective review was performed on 247 breast cancer patients with bone metastases identified on axial skeleton MRI. MRI studies were reviewed for metastases T1 signal, signal uniformity, complete vertebral metastatic marrow replacement, metastases quantity, and distribution. Odds ratio (OR) and hazard ratios (HR) were calculated, with 95 % confidence intervals (95 % CI), to determine association with either future SREs or survival. At the time of analysis, 174 (70 %) patients had developed SREs and 176 (71 %) patients were dead. Features of skeletal metastases associated with SREs included the presence of complete metastatic marrow replacement within any vertebra; OR 2.363 (95 % CI 1.240–4.504, P = 0.0090), and more widely distributed metastases; OR 1.239 (95 % CI 1.070–1.435, P = 0.0040). Features associated with shorter survival included the presence of complete metastatic marrow replacement within any vertebra; HR 1.500 (95 % CI 1.105–2.036, P = 0.0093), and more widely distributed metastases; HR 1.141 (95 % CI 1.047–1.243, P = 0.0027). Metastases T1 signal, signal uniformity, and surprisingly quantity were not associated with SREs or survival. Axial skeleton MRI was able to identify characteristics predictive of future SREs and survival. These characteristics could be used for risk stratification for future trials if prospectively validated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

SRE:

Skeletal-related events

MRI:

Magnetic resonance imaging

OR:

Odds ratio

HR:

Hazard ratios

CI:

Confidence intervals

ICC:

Intraclass correlation coefficients

References

  1. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271–278

    Article  CAS  PubMed  Google Scholar 

  3. Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ (1992) Human breast cancer: survival from first metastasis. Breast cancer study group. Breast Cancer Res Treat 21:173–180

    Article  CAS  PubMed  Google Scholar 

  4. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56:67–78

    Article  CAS  PubMed  Google Scholar 

  5. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197–2205

    CAS  PubMed  Google Scholar 

  6. Yeatman TJ (1995) The natural history of locally advanced primary breast carcinoma and metastatic disease. Surg Oncol Clin N Am 4:569–589

    CAS  PubMed  Google Scholar 

  7. Kuchuk I, Clemons M, Addison C (2012) Time to put an end to the “one size fits all” approach to bisphosphonate use in patients with metastatic breast cancer? Curr Oncol 19:e303–e304

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Clemons M, Gelmon KA, Pritchard KI, Paterson AHG (2012) Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art. Curr Oncol 19:259–268

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Jensen AO, Jacobsen JB, Norgaard M, Yong M, Fryzek JP, Sorensen HT (2011) Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 11:29

    Article  PubMed Central  PubMed  Google Scholar 

  10. Costa L, Badia X, Chow E, Lipton A, Wardley A (2008) Impact of skeletal complications on patients’ quality of life, mobility, and functional independence. Support Care Cancer 16:879–889

    Article  PubMed  Google Scholar 

  11. Costa L, Major PP (2009) Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nat Clin Pract Oncol 6:163–174

    Article  CAS  PubMed  Google Scholar 

  12. Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE (2010) Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Res Treat 123:767–779

    Article  PubMed  Google Scholar 

  13. Trinkaus M, Simmons C, Myers J, Dranatisaris G, Clemons M (2010) Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting. Support Care Cancer 18:197–203

    Article  PubMed  Google Scholar 

  14. Lipton A, Cook R, Saad F et al (2008) Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer 113:193–201

    Article  CAS  PubMed  Google Scholar 

  15. DePuy V, Anstrom K, Castel L, Schulman K, Weinfurt K, Saad F (2007) Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 15:869–876

    Article  PubMed  Google Scholar 

  16. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187

    Article  CAS  PubMed  Google Scholar 

  17. Yong M, Jensen AO, Jacobsen JB, Norgaard M, Fryzek JP, Sorensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007). Breast Cancer Res Treat 129:495–503

    Article  PubMed  Google Scholar 

  18. Eustace S, Tello R, DeCarvalho V et al (1997) A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR 169:1655–1661

    Article  CAS  PubMed  Google Scholar 

  19. Lauenstein TC, Goehde SC, Herborn CU et al (2004) Whole-body MR imaging: evaluation of patients for metastases. Radiology 233:139–148

    Article  PubMed  Google Scholar 

  20. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA (2004) Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14:99–105

    Article  CAS  PubMed  Google Scholar 

  21. Yang H-L, Liu T, Wang X-M, Xu Y, Deng S-M (2011) Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 21:2604–2617

    Article  PubMed  Google Scholar 

  22. Yuh WT, Zachar CK, Barloon TJ, Sato Y, Sickels WJ, Hawes DR (1989) Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. Radiology 172:215–218

    Article  CAS  PubMed  Google Scholar 

  23. Vanel D, Bittoun J, Tardivon A (1998) MRI of bone metastases. Eur Radiol 8:1345–1351

    Article  CAS  PubMed  Google Scholar 

  24. Baker LL, Goodman SB, Perkash I, Lane B, Enzmann DR (1990) Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging. Radiology 174:495–502

    Article  CAS  PubMed  Google Scholar 

  25. Noguchi M, Kikuchi H, Ishibashi M, Noda S (2003) Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer. Br J Cancer 88:195–201

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Imbriaco M, Larson SM, Yeung HW et al (1998) A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res 4:1765–1772

    CAS  PubMed  Google Scholar 

  27. Sabbatini P, Larson SM, Kremer A et al (1999) Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol 17:948–957

    CAS  PubMed  Google Scholar 

  28. Loeffler RK, DiSimone RN, Howland WJ (1975) Limitations of bone scanning in clinical oncology. JAMA 234:1228–1232

    Article  CAS  PubMed  Google Scholar 

  29. Brown AL, Middleton G, MacVicar AD, Husband JE (1998) T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correlation with response to therapy. Clin Radiol 53:493–501

    Article  CAS  PubMed  Google Scholar 

  30. Byun WM, Shin SO, Chang Y, Lee SJ, Finsterbusch J, Frahm J (2002) Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR Am J Neuroradiol 23:906–912

    PubMed  Google Scholar 

  31. Major PP, Cook RJ, Lipton A, Smith MR, Terpos E, Coleman RE (2009) Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer 9:272

    Article  PubMed Central  PubMed  Google Scholar 

  32. Koizumi M, Yoshimoto M, Kasumi F, Ogata E (2003) Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol 14:1234–1240

    Article  CAS  PubMed  Google Scholar 

  33. Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD (2001) Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 91:17–24

    Article  CAS  PubMed  Google Scholar 

  34. Grankvist J, Fisker R, Iyer V et al (2012) MRI and PET/CT of patients with bone metastases from breast carcinoma. Eur J Radiol 81:e13–e18

    Article  CAS  PubMed  Google Scholar 

  35. Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL Jr, Ma J (2013) Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging 31:669–675

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful for assistance with statistical analysis from Tinghua Zhang, M.Sc. from the Ottawa Hospital Research Institute.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

The authors declare that this study complies with all laws within the country that it was conducted.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian B. van der Pol.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Pol, C.B., Schweitzer, M.E., Di Primio, G. et al. Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival. Breast Cancer Res Treat 146, 583–589 (2014). https://doi.org/10.1007/s10549-014-3046-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3046-z

Keywords

Navigation